Latin America Bio Pharmaceuticals market by Product Type (Monoclonal Antibodies (mAb), Erythropoietin, Biotech Vaccines, Recombinant Human (RH) Insulin, Granulocyte colony-stimulating factor (G-CSF), Interferon and Human growth hormones (HGH)) by Therapeutic Type (Neurology, Infectious diseases, Diabetes, Oncology, Cardiovascular and Other Therapeutic Areas), and by Region - Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2016–2021)

Latin America Bio Pharmaceuticals market by Product Type (Monoclonal Antibodies (mAb), Erythropoietin, Biotech Vaccines, Recombinant Human (RH) Insulin, Granulocyte colony-stimulating factor (G-CSF), Interferon and Human growth hormones (HGH)) by Therapeutic Type (Neurology, Infectious diseases, Diabetes, Oncology, Cardiovascular and Other Therapeutic Areas), and by Region - Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2016–2021)

ID: 637 | Pages: 140 | October 2016 | Region: Latin America


The Latin America Bio Pharmaceuticals market was worth $22.6 billion in 2016 and estimated to be growing at a CAGR of 9.67%, to reach $35.85 billion by 2021.

Biopharmaceuticals industry has come a long way since approval of its first drug. Now, several drugs have already been approved and many more are in last stages of their clinical trial. These drugs have not only innovated the prevention and treatment of a number of life threatening diseases but have also delivered the thrust for the constant success of the pharmaceutical industry. Several companies are inclining their research to biopharmaceuticals as one drug approved for market selling can represent goldmines for the investors.

A rich late stage pipeline and growing demand in developing markets are projected to be major drivers in the forecast period. The biopharmaceuticals market is observing substantial growth due to growing incidence of chronic diseases, rising aging population, technological advancements in biopharmaceuticals, and increasing R&D investments. Despite of growth of the market, some challenges are faced such as supply chain complexity, lack of developed cold-chain maintenance and stringent approval and production laws.

The Latin America bio pharmaceuticals market is segmented on the basis of products into Monoclonal Antibodies (mAb), Erythropoietin, Biotech Vaccines, Recombinant Human (RH) Insulin, Granulocyte colony-stimulating factor (G-CSF), Interferon and Human growth hormones (HGH). Monoclonal antibodies segment holds the highest number of shares in the product sector. Based on therapeutics, the market is bifurcated into Neurology, Infectious diseases, Diabetes, Oncology, Cardiovascular and other therapeutic areas. In terms of therapeutic application, oncology is the largest segment in the biopharmaceuticals market.

Based on geography the market is analysed under various regions namely, Mexico, Brazil and Argentina. Mexico dominates the Latin America market and is expected to lead in the forecast period.

Merck & Co., Inc., F. Hoffmann-La Roche AG, Eli Lilly and Company, Inc., Sanofi, Amgen Inc., AbbVie Inc., Biogen Idec, Bayer AG, Johnson & Johnson Services, Pfizer, Inc., and Novartis AG are some of the leading players in the market for biopharmaceuticals.

1. Introduction                                 

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 New Developments                               

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 By Product Type                       

                                5.1.1 Monoclonal Antibodies (mAb)       

                                5.1.2 Erythropoietin       

                                5.1.3 Biotech Vaccines  

                                5.1.4 Recombinant Human (RH) Insulin 

                                5.1.5 Granulocyte colony-stimulating factor (G-CSF)       

                                5.1.6 Interferon               

                                5.1.7 Human growth hormones (HGH)  

                5.2 By Therapeutic Type                               

                                5.2.1 Neurology               

                                5.2.2 Infectious diseases              

                                5.2.3 Diabetes  

                                5.2.4 Oncology 

                                5.2.5 Cardiovascular       

                                5.2.6 Other Therapeutic Areas  

6. Geographical Analysis                                              

                                6.1 Introduction               

                                6.2 Brazil             

                                6.3 Mexico         

                                6.4 Argentina    

                                6.5 Rest of Latin America             

7. Strategic Analysis                                       

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8. Market Leaders' Analysis                                        

                8.1 Merck & Co.                               

                                8.1.1 Overview 

                                8.1.2 Product Analysis   

                                8.1.3 Strategic Evaluation and Operations            

                                8.1.4 Financial analysis  

                                8.1.5 Legal issues             

                                8.1.6 Recent Developments       

                                8.1.7 SWOT analysis       

                                8.1.8 Analyst View          

                8.2 F. Hoffmann-La Roche AG                    

                8.3 Eli Lilly and Company                              

                8.4 Sanofi                           

                8.5 Amgen Inc.                 

                8.6 AbbVie Inc.                 

                8.7 Biogen Idec                

                8.8 Bayer AG                     

                8.9 Johnson & Johnson Services                               

                8.10 Pfizer                          

                8.11 Novartis AG                             

9. Competitive Landscape                                           

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10. Expert Opinions                                        

                10.1 Market Outlook                     

                10.2 Investment Opportunities                 

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market

TitlePriceAdd To Cart
  1. Latin America Bio Pharmaceuticals Market By Region, From 2016-2021 (USD Billion)
  2. Latin America Bio Pharmaceuticals Market By Product Type, From 2016-2021 (USD Billion)
  3. Latin America Monoclonal Antibodies (mAb) Market By Region, From 2016-2021 (USD Billion)
  4. Latin America Erythropoietin Market By Region, From 2016-2021 (USD Billion)
  5. Latin America Biotech Vaccines Market By Region, From 2016-2021 (USD Billion)
  6. Latin America Recombinant Human (RH) Insulin Market By Region, From 2016-2021 (USD Billion)
  7. Latin America Granulocyte colony-stimulating factor (G-CSF) Market By Region, From 2016-2021 (USD Billion)
  8. Latin America Interferon Market By Region, From 2016-2021 (USD Billion)
  9. Latin America Human growth hormones (HGH) Market By Region, From 2016-2021 (USD Billion)
  10. Latin America Bio Pharmaceuticals Market By Therapeutic Type, From 2016-2021 (USD Billion)
  11. Latin America Neurology Market By Region, From 2016-2021 (USD Billion)
  12. Latin America Infectious diseases Market By Region, From 2016-2021 (USD Billion)
  13. Latin America Diabetes Market By Region, From 2016-2021 (USD Billion)
  14. Latin America Oncology Market By Region, From 2016-2021 (USD Billion)
  15. Latin America Cardiovascular Market By Region, From 2016-2021 (USD Billion)
  16. Latin America Other Therapeutic Areas Market By Region, From 2016-2021 (USD Billion)
  17. Brazil Bio Pharmaceuticals Market By Product Type, From 2016-2021 (USD Billion)
  18. Brazil Bio Pharmaceuticals Market By Therapeutic Type, From 2016-2021 (USD Billion)
  19. Argentina Bio Pharmaceuticals Market By Product Type, From 2016-2021 (USD Billion)
  20. Argentina Bio Pharmaceuticals Market By Therapeutic Type, From 2016-2021 (USD Billion)
  21. Mexico Bio Pharmaceuticals Market By Product Type, From 2016-2021 (USD Billion)
  22. Mexico Bio Pharmaceuticals Market By Therapeutic Type, From 2016-2021 (USD Billion)

"We Think Through Different Layers, We Work Across Different Verticals."

Market Data Forecast, Inc.
502, kakatiya's empire,
Jubilee Gardens,
Hyderabad, India.
+1-888-702-9626 (U.S. TOLL FREE)
contact@marketdataforecast.com


Subscribe To Our News Letter

Or follow us on social platform

© 2017 Market Data Forecast
All Rights Reserved.